Relievant Medsystems
company
About
Relievant provides patients with low risk therapy that affords the ability to alleviate their back pain.
- 101 - 250
Highlights
Details
- Last Funding Type
- Series E
- Last Funding Money Raised
- $58M
- Industries
- Biotechnology,Health Care,Medical
- Founded date
- Jan 1, 2006
- Number Of Employee
- 101 - 250
- Operating Status
- Active
Relievant provides patients with low risk therapy that affords the ability to alleviate their back pain. tTe company's Relievant’s Intracept® System delivers targeted energy into the spine and blocks the transmission of pain signals from the basivertebral nerve.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$58M
Relievant Medsystems has raised a total of
$58M
in funding over 2 rounds. Their latest funding was raised on
Jun 26, 2018 from a Series E round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 26, 2018 | Series E | $58M | 1 | — | — | Detail |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
